The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species
Open accessAbstract
BACKGROUND: Zinc oxide nanoparticles (ZnO NPs) have received much attention for their implications in cancer therapy. It has been reported that ZnO NPs induce selective killing of cancer cells. However, the underlying molecular mechanisms behind the anticancer response of ZnO NPs remain unclear. METHODS AND RESULTS: We investigated the cytotoxicity of ZnO NPs against three types of cancer cells (human hepatocellular carcinoma HepG2, human lung adenocarcinoma A549, and human bronchial epithelial BEAS-2B) and two primary rat cells (astrocytes and hepatocytes). Results showed that ZnO NPs exert distinct effects on mammalian cell viability via killing of all three types of cancer cells while posing no impact on normal rat astrocytes and hepatocytes. The toxicity mechanisms of ZnO NPs were further investigated using human liver cancer HepG2 cells. Both the mRNA and protein levels of tumor suppressor gene p53 and apoptotic gene bax were upregulated while the antiapoptotic gene bcl-2 was downregulated in ZnO NP-treated HepG2 cells. ZnO NPs were also found to induce activity of caspase-3 enzyme, DNA fragmentation, reactive oxygen species generation, and oxidative stress in HepG2 cells. CONCLUSION: Overall, our data demonstrated that ZnO NPs selectively induce apoptosis in cancer cells, which is likely to be mediated by reactive oxygen species via p53 pathway, through which most of the anticancer drugs trigger apoptosis. This study provides preliminary guidance for the development of liver cancer therapy using ZnO NPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Cited by
The Advancing of Zinc Oxide Nanoparticles for Biomedical Applications
Jiang, J., Pi, J., & Cai, J. (2018) · Bioinorganic Chemistry and Applications · doi:10.1155/2018/1062562 · Cited by 1,255
Zinc oxide nanoparticles: Biological synthesis and biomedical applications
Mirzaei, H., & Darroudi, M. (2017) · Ceramics International · doi:10.1016/j.ceramint.2016.10.051 · Cited by 840
Antibacterial properties and toxicity from metallic nanomaterials
Vimbela, G., Ngo, S. M., Fraze, C., Yang, L., & Stout, D. A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s134526 · Cited by 640
Selim, Y. A., Azb, M. A., Ragab, I., & H. M. Abd El-Azim, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-60541-1 · Cited by 552
Soenen, S. J., Parak, W. J., Rejman, J., & Manshian, B. (2015) · Chemical Reviews · doi:10.1021/cr400714j · Cited by 515
Metadata
- Authors
- Ahamed, M., Akhtar, J., Kumar, Khan, M., Ahmad, & Alrokayan
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2012-02
- Volume
- 7
- Pages
- 845
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2038503712
- Cited by
- 701
- References
- 2
- FWCI
- 16.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.